61 related articles for article (PubMed ID: 9478054)
1. [The role of 99mTc-MIBI mammoscintigraphy in the diagnosis of breast cancer].
Ambrus E; Ormándi K; Séra T; Tószegi A; Csernay L; Pávics L
Orv Hetil; 1998 Jan; 139(4):183-7. PubMed ID: 9478054
[TBL] [Abstract][Full Text] [Related]
2. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.
Kawata K; Kanai M; Sasada T; Iwata S; Yamamoto N; Takabayashi A
Clin Cancer Res; 2004 Jun; 10(11):3788-93. PubMed ID: 15173086
[TBL] [Abstract][Full Text] [Related]
4. Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis.
Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
Breast Cancer Res Treat; 2004 Jan; 83(2):129-38. PubMed ID: 14997043
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of 99mTc-MIBI and 99mTc-HMDP scintimammography for the diagnosis of breast cancer and its axillary metastases.
Nishiyama Y; Yamamoto Y; Ono Y; Irie A; Yamauchi A; Satoh K; Ohkawa M
Eur J Nucl Med; 2001 Apr; 28(4):522-8. PubMed ID: 11357504
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of (99m)Tc-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with X-rays mammography, ultrasonography and magnetic resonance imaging.
Ozülker T; Ozülker F; Ozpaçaci T; Bender O; Değirmenci H
Hell J Nucl Med; 2010; 13(2):144-9. PubMed ID: 20808988
[TBL] [Abstract][Full Text] [Related]
7. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
Villanueva-Meyer J; Leonard MH; Briscoe E; Cesani F; Ali SA; Rhoden S; Hove M; Cowan D
J Nucl Med; 1996 Jun; 37(6):926-30. PubMed ID: 8683313
[TBL] [Abstract][Full Text] [Related]
8. Clinical importance of (99m)Tc-MIBI mammoscintigraphy in multifocal breast lesions.
Piwkowski P; Zielińska D; Kołodziejczyk A; Zawisza R; Zebrowski J; Patrzyk R
Nucl Med Rev Cent East Eur; 2006; 9(2):144-6. PubMed ID: 17304478
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic accuracy of mammography and mammoscintigraphy in multifocal breast cancer].
Krivorot'ko PV
Vopr Onkol; 2013; 59(1):59-64. PubMed ID: 23805452
[TBL] [Abstract][Full Text] [Related]
10. Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy.
Maurer AH; Caroline DF; Jadali FJ; Manzone TA; Maier WP; Au FC; Schnall SF
J Nucl Med; 1995 Sep; 36(9):1696-700. PubMed ID: 7658233
[TBL] [Abstract][Full Text] [Related]
11. Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer.
Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
Eur J Radiol; 2005 Feb; 53(2):192-8. PubMed ID: 15664282
[TBL] [Abstract][Full Text] [Related]
12. Dynamic imaging: scintimammography.
Salvatore M; Del Vecchio S
Eur J Radiol; 1998 May; 27 Suppl 2():S259-64. PubMed ID: 9652532
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of technetium-99m tetrofosmin mammoscintigraphy as compared to mammography for detecting and differentiating palpable breast masses of young Taiwanese women.
Hoi YJ; Hsieh JF; Tsai SC; Sun SS; Kao CH
Anticancer Res; 2000; 20(3B):2061-4. PubMed ID: 10928152
[TBL] [Abstract][Full Text] [Related]
14. Comparison of early and delayed quantified indices of double-phase (99m)Tc MIBI scintimammography in the detection of primary breast cancer.
Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
Acta Radiol; 2005 Apr; 46(2):148-54. PubMed ID: 15902889
[TBL] [Abstract][Full Text] [Related]
15. [Breast scintigraphy with technetium 99m sestamibi, as support to radiologic methods in the study of breast lesions].
Occhiato R; Schillaci O; Broglia L; Danieli R; Narilli P; Pavone P; Scopinaro F; Passariello R
Radiol Med; 1996 May; 91(5):581-4. PubMed ID: 8693123
[TBL] [Abstract][Full Text] [Related]
16. [Differentiation of benign and malignant palpable breast masses using 99mTc-MIBI imaging].
He J; Li Y; Su J
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):226-8. PubMed ID: 9868120
[TBL] [Abstract][Full Text] [Related]
17. 99Tcm-MIBI mammoscintigraphy of breast masses: early and delayed imaging.
Lu G; Shih WJ; Huang HY; Long MQ; Sun Q; Liu YH; Chou C
Nucl Med Commun; 1995 Mar; 16(3):150-6. PubMed ID: 7770238
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonography.
Burak Z; Argon M; Memiş A; Erdem S; Balkan Z; Duman Y; Ustün EE; Erhan Y; Ozkiliç H
Nucl Med Commun; 1994 Aug; 15(8):604-12. PubMed ID: 7970442
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of 99mTc-MIBI breast imaging in the diagnosis of early breast cancer.
Ren C; Jin S; Zhou Q; Zhu H; Wang H; Liang C
Asian J Surg; 2002 Apr; 25(2):126-9. PubMed ID: 12376231
[TBL] [Abstract][Full Text] [Related]
20. Role of thallium-201 chloride and Tc-99m methoxy-isobutyl-isonitrite (sestaMIBI) in evaluation of breast masses: correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, Bcl, and angiogenesis) in malignant lesions.
Omar WS; Eissa S; Moustafa H; Farag H; Ezzat I; Abdel-Dayem HM
Anticancer Res; 1997; 17(3B):1639-44. PubMed ID: 9179210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
